Lind Global Fund II LP 13D and 13G filings for Kintara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-20 5:11 pm Purchase |
2022-04-14 | 13G | Kintara Therapeutics, Inc. KTRA |
Lind Global Fund II LP | 2,156 5.800% |
2,156 (New Position) |
Filing |